Price $1.46 |
Market Cap
185.7M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.65
|
P/S
16.94
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-35K
|
FCF
-0.3
|
|
Op. Margin
-814.20%
|
Net Margin
-842.30%
|
ROE
-71.50%
|
ROI
-78.10%
|
|
ROA
-51.80%
|
EPS Growth
40.30%
|
Current Ratio
2.3
|
Debt/Equity
1.40%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| NuVasive, Inc. (NUVA) | $68.88 | - | - | 3.37B | Strong Buy |
| Teva Pharmaceutical Industries (TEVA) | $10.11 | - | - | 12.5B | Strong Buy |
| Medicure Inc (MCUJF) | $1.30 | - | - | 12.6M | Strong Buy |
| Bristol-Myers Squibb Co (BMY) | $66.08 | - | 3.10% | 141.03B | Strong Buy |
| Cumberland Pharmaceuticals, In (CPIX) | $2.97 | - | - | 45.2M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
